Check out what happened in biotech on friday just before market close. ANDS had a nice spike right before the market closed jumping up 66 cents a share to close at $2.97. This should be a reaction to the news that they are returning to Hep C treatment with their drug termed ANA598:
Anadys Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing medicines in the areas of hepatitis C and oncology. It develops ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C; and ANA773, an oral toll-like receptor 7 agonist prodrug for cancer. The company was founded in 1992. It was formerly known as ScripTech Pharmaceuticals, Inc. and changed its name to Scriptgen Pharmaceuticals, Inc. in 1994. Later, the company changed its name to Anadys Pharmaceuticals, Inc. in 2000. Anadys Pharmaceuticals is headquartered in San Diego, California.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment